A Clinical Trial to syudy the effect of Arjun-Jatamansyadi Churna in High Blood Pressure

To Study The Effect of Arjun-Jatamansyadi Churna in Essential Hypertension

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021729

Enrollment

220

Registered

2019-10-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Arjun-Jatamansyadi Churna: Contents: Arjun, Jatamansi, Gokshur, Haritaki, Manishtha (All 2 gm each) 5 gm BD for 3 Months Control Intervention1: Tab. Telmisartan: 40 mg OD for 3 Months

Eligibility

Inclusion criteria

Inclusion criteria: Stage I Hypertension (Systolic Blood Pressur is 140 to 159 mm of Hg and Diastolic Blood Pressure is 90 to 99 mm of Hg)

Exclusion criteria

Exclusion criteria: 1. Secondary Hypertension 2. Patients having history of Acute Coronary Syndrome, Cardiomyopathies, Myocardial Infarction, Stroke, IHD, CHD, CAD. Co-arctation of Aorta 3. Pregnant, Lactating Women and Who is under Estrogen replacement Therapy 4. Alcohol and Drug Abusers 5. Accelerated and Malignant Hypertension 6. Complicated Multiple Organ Failure 7. Nephropathy, Encephalopathy, Endocrine Disorders 8. Mentally Ill Patients 9. Metabolic Syndrome

Design outcomes

Primary

Measure	Time frame
Blood PressureTimepoint: 0 Day, 15th Day, 30th Day, 45th Day, 60th Day, 75th Day and 90th Day	—

Secondary

Measure	Time frame
ECGTimepoint: 0 Day and 90th Day;Urine Routine and MicroscopyTimepoint: 0 Day and 90th Day	—

Countries

India

Contacts

Public ContactDr Mukund M More

BBSPMs Dhanwantari Ayurved Medical College and Hospital

drnarayanj52@gmail.com9822675803

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026